Click on a filter below to refine your search. Remove a filter to broaden your search.
New tech for stroke, including AI and a robotic hip device, aims to improve treatment at every stage from diagnosis to recovery.
Proportionately lower log odds were seen for heart disease, heart attack, stroke and composite outcome for days of use between zero and 30 a month.
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.